SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898430-97-003759
Filing Date
1997-08-29
Accepted
1997-08-29 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF PARTNERS, L.P.BVF, INC.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 19251
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1324
3 TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS EX-99.B 1562
  Complete submission text file 0000898430-97-003759.txt   24512
Mailing Address 1065 E HILLSDALE BLVD SUITE 418 FORSTER CITY CA 94404
Business Address 1065 E HILLSDALE BLVD SUITE 418 FORSTER CITY CA 94404 4153826770
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45279 | Film No.: 97673212
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice